Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues

O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues

US Patent 9707276 · Granted Jul 18, 2017

Estimated economic value: $61,300,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2025
Co-agonists at GLP-1 and GIP receptors suitable for oral delivery2023
GIP derivatives and uses thereof2023
FGF21 C-terminal peptide optimization2022
FGF21 C-terminal peptide optimization2022
Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof2021
Display device having NFC communication function2021
Glucagon/GLP-1 receptor co-agonists2020
Insulin-incretin conjugates2020
Insulin-incretin conjugates2020
Aqueously soluble and chemically stable glucagon peptides2020